
LOBSTECH
Indonesia · Agri & FoodTech · Undetermined

Pleryon Therapeutics
China · Biotech & life sciences · Series A
Compatibility /100
49/100
Medium potentialWhy talk
- Pleryon Therapeutics (China) is a regional neighbour in Asia — a natural first step for cross-border expansion.
- LOBSTECH likely needs funding — Pleryon Therapeutics (China, Series A, $18.6M raised) can offer investor introductions (inferred from public profile).
- Complementary sectors: Agri & FoodTech × Biotech & life sciences — room for a joint offer or co-selling.
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
12.5 / 25 pts
Pleryon Therapeutics can help LOBSTECH.
- LOBSTECH likely needs funding — Pleryon Therapeutics (China, Series A, $18.6M raised) can offer investor introductions (inferred from public profile).
Market bridge
22.5 / 45 pts
Regional bridge.
- Pleryon Therapeutics (China) is a regional neighbour in Asia — a natural first step for cross-border expansion.
Customer potential
1.0 / 10 pts
No obvious buyer/seller or shared customer base.
No supporting signal in the records.
Sector synergy
8.5 / 10 pts
Complementary sectors.
- Complementary sectors: Agri & FoodTech × Biotech & life sciences — room for a joint offer or co-selling.
Stage complementarity
4.5 / 10 pts
Weak stage signal.
- Pleryon Therapeutics has raised about $18.6M — investor introductions are realistic.
- Stage not comparable (Undetermined / Series A).
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Market entry”: Needs ↔ offers 25, Market bridge 45, Customer potential 10, Sector synergy 10, Stage complementarity 10. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 48/100 — high from 50, medium from 36.